(lp0
S'Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 ... GlobeNewswire  - Oct 5, 2016 BRIDGEWATER, N.J., Oct. 05, 2016  -- Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced a licensing agreement with AstraZeneca&nbsp;...'
p1
aS'Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference ... GlobeNewswire  - Feb 16, 2017 BRIDGEWATER, N.J., Feb. 16, 2017  -- Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release its fourth quarter and&nbsp;...'
p2
aS'Insmed Inc. INSM  Wall Street Journal - Feb 14, 2011 Lifshitz &amp; Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc. Press Release. 01/04/17&nbsp;...'
p3
aS'Insmed Incorporated and Transave, Inc. Announce Business Combination PR Newswire  - Dec 2, 2010 After giving effect to the merger, former Transave stockholders have approximately a 46.7% equity interest in the combined company , and Insmed Incorporated shareholders have a 53.3% interest on a fully diluted,&nbsp;...'
p4
aS"Why Insmed Incorporated Shares Skyrocketed Motley Fool - Jun 18, 2014 What: Shares of Insmed , a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious lung diseases, surged as much as 41% this morning after announcing that the Food and Drug Administration had granted&nbsp;...Insmed's  ARIKAYCE Granted Breakthrough Designation by FDA - StreetInsider.com Insmed Soars on Arikayce's Breakthrough Designation - Zacks.com"
p5
aS'Company Update : Insmed Incorporated Appoints Roger Adsett as ... Smarter Analyst - Sep 27, 2016 Insmed Incorporated  announced the appointment of Roger Adsett as chief commercial officer. Mr. Adsett was most recently senior vice president, head of the gastrointestinal and internal medicine business unit at Shire plc.'
p6
aS'Stock Update : Insmed Incorporated Reports Third Quarter 2015 ... Smarter Analyst - Nov 6, 2015 Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported financial results for the third quarter and nine months ended September 30, 2015.'
p7
aS"Stock Update : Insmed Incorporated Announces Withdrawal of ... Smarter Analyst - Jun 8, 2016 Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it has withdrawn its Marketing Authorization Application  from the European Medicines&nbsp;...Insmed  Stock: Here's Why It's Falling - CNA Finance "
p8
aS'Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 ... GlobeNewswire  - May 3, 2016 BRIDGEWATER, N.J., May 03, 2016  -- Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that three ARIKAYCE-related abstracts and&nbsp;...'
p9
aS"Insmed Incorporated to Present Data on Liposomal Technology To Treat PAH, IPF ... Lung Disease News - May 9, 2016 ARIKAYCE  is an investigational drug comprising the antibiotic amikacin in Insmed's proprietary liposomal technology formulation. ARIKAYCE is being investigated for the treatment of serious lung infections ..."
p10
a.